Par Drugs and Chemicals Limited (NSE:PAR)

India · Delayed Price · Currency is INR

141.70

+0.62 (0.44%)

Sep 11, 2026, 3:29 PM IST

Market Cap	1.73B +24.2%
Revenue (ttm)	1.09B +4.3%
Net Income	144.93M +2.4%
EPS	11.78 +2.4%
Shares Out	12.30M
PE Ratio	11.96
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,365
Open	141.99
Previous Close	141.08
Day's Range	134.03 - 147.96
52-Week Range	78.05 - 180.00
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Par Drugs and Chemicals

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, a... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1982

Employees 121

Stock Exchange National Stock Exchange of India

Ticker Symbol PAR

Full Company Profile

Financial Performance

In fiscal year 2026, Par Drugs and Chemicals's revenue was 1.04 billion, an increase of 2.66% compared to the previous year's 1.01 billion. Earnings were 131.09 million, a decrease of -1.87%.

Financial Statements